Anticorpi anti-glutamat decarboxilaza (GAD) in LCR - Synevo
Excellent response to steroid treatment in anti-GAD cerebellar ataxia - The Lancet Neurology
Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: A comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus - ScienceDirect
Comparison of CSF anti-GAD antibody titers within a 2-year period.... | Download Scientific Diagram
Comparison of CSF anti-GAD antibody titers within a 2-year period.... | Download Scientific Diagram
Research of anti-GAD and anti-IA2 autoantibodies by ELISA test in a series of Moroccan pediatric patients with diabetes type 1
Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature - ScienceDirect
Stiff Person Syndrome and Type 1 Diabetes Mellitus: a Case of the Chicken or the Egg? | SpringerLink
GAD antibodies in neurological disorders — insights and challenges | Nature Reviews Neurology
Autoanticorpi anti-GAD e diabete autoimmune - Portale Diabete
Neurologic syndromes related to anti-GAD65 | Neurology Neuroimmunology & Neuroinflammation
Diagnostic accuracy of the anti‐glutamic acid decarboxylase antibody in type 1 diabetes mellitus: Comparison between radioimmunoassay and enzyme‐linked immunosorbent assay - Murata - 2017 - Journal of Diabetes Investigation - Wiley Online Library
GAD antibodies in neurological disorders — insights and challenges | Nature Reviews Neurology
Dosaggio anticorpi anti-GAD Archivi - Laboratorio Analisi Cliniche Ciaffi Roma
_13072011_.png "18/01/2019 – Tornano campioni sangue anticorpi prelievo del 07 e 09/01/2019 – ANTI GAD positivi")
18/01/2019 – Tornano campioni sangue anticorpi prelievo del 07 e 09/01/2019 – ANTI GAD positivi
Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital. | Semantic Scholar
PDF) Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity | Kuntal Bhadra - Academia.edu
فحص هام لمريض السكري ANti Gad.... - مختبر هاي لاب الطبي-جنين | فيسبوك
Anticorpos Anti GAD – Cedirlab
Pro- and anti-inflammatory response in neurological disorders associated to anti-glutamate decarboxylase antibodies - ScienceDirect
Gli anticorpi IA-2256-760 mostrano la stessa frequenza dei GAD in pazienti con DM2: studio SUMMER – Il Diabete Online
Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies | SpringerLink
![PDF] Baja prevalencia de autoinmunidad (anticuerpos anti GAD +) en pacientes adultos con diabetes tipo 2 de inicio temprano by Israel Lerman, Julio Granados, Carlos A Aguilar-Salinas, Marlette Lobato, Antonio R. Villa,](https://og.oa.mg/Baja%20prevalencia%20de%20autoinmunidad%20(anticuerpos%20anti%20GAD%20+)%20en%20pacientes%20adultos%20con%20diabetes%20tipo%202%20de%20inicio%20temprano.png?author=%20Israel%20Lerman,%20Julio%20Granados,%20Carlos%20A%20Aguilar-Salinas,%20Marlette%20Lobato,%20Antonio%20R.%20Villa,%20Mar%C3%ADa%20Luisa%20Velasco,%20Francisco%20J.%20G%C3%B3mez-P%C3%A9rez "PDF] Baja prevalencia de autoinmunidad (anticuerpos anti GAD +) en pacientes adultos con diabetes tipo 2 de inicio temprano by Israel Lerman, Julio Granados, Carlos A Aguilar-Salinas, Marlette Lobato, Antonio R. Villa,")
PDF] Baja prevalencia de autoinmunidad (anticuerpos anti GAD +) en pacientes adultos con diabetes tipo 2 de inicio temprano by Israel Lerman, Julio Granados, Carlos A Aguilar-Salinas, Marlette Lobato, Antonio R. Villa,
SciELO - Brasil - Prevalência dos marcadores imunológicos Anti-GAD e Anti-IA2 em parentes de primeiro grau de diabéticos do tipo 1 em amostra da população da Grande São Paulo Prevalência dos marcadores
Les Anticorps du Diabète - ppt video online télécharger
